{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:50:24Z","timestamp":1791993024621,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003135","name":"Minnesota Ovarian Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajog.2025.10.044","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:45:28Z","timestamp":1762011928000},"page":"1003-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-9441","authenticated-orcid":false,"given":"Roni Nitecki","family":"Wilke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn P.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar A.","family":"Gootzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda P.","family":"Steenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara C.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.10.044_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2025.10.044_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2025.10.044_bib3","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.10.044_bib4","series-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) genetic\/familial high-risk assessment: breast, Ovarian, and Pancreatic Version 1.2026","year":"2025"},{"key":"10.1016\/j.ajog.2025.10.044_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaoncol.2023.6937","article-title":"Bilateral oophorectomy and all-cause mortality in women with BRCA1 and BRCA2 sequence variations","volume":"10","author":"Kotsopoulos","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2021.07.029","article-title":"What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy","volume":"163","author":"Hickey","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-Oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.38663","article-title":"Association of premenopausal bilateral oophorectomy with parkinsonism and parkinson disease","volume":"5","author":"Rocca","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.10.044_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00198-020-05608-5","article-title":"Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM study)","volume":"32","author":"Jiang","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajog.2025.10.044_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10897-017-0069-8","article-title":"\u201cIt was an emotional Baby\u201d: previvors' Family Planning Decision-making Styles about Hereditary Breast and Ovarian Cancer Risk","volume":"26","author":"Dean","year":"2017","journal-title":"J Genet Couns"},{"key":"10.1016\/j.ajog.2025.10.044_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1049732319885113","article-title":"BRCA and motherhood: a matter of time and timing","volume":"30","author":"Possick","year":"2020","journal-title":"Qual Health Res"},{"key":"10.1016\/j.ajog.2025.10.044_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2025.10.044_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2016.07.104","article-title":"Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers: a single-center experience","volume":"143","author":"Harmsen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/1471-0528.16424","article-title":"Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study","volume":"128","author":"Gaba","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2025.10.044_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/humrep\/deu034","article-title":"Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer","volume":"29","author":"Derks-Smeets","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2025.10.044_bib19","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","article-title":"Microscopic and early-stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis","volume":"4","author":"Yates","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ajog.2025.10.044_bib22","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","article-title":"Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy","volume":"18","author":"Lu","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2025.10.044_bib25","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2025.10.044_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/GCO.0000000000000204","article-title":"Role of salpingectomy at the time of urogynecologic surgery","volume":"27","author":"Bradley","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae161","article-title":"Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review","volume":"9","author":"Fisch","year":"2024","journal-title":"BJS Open"},{"key":"10.1016\/j.ajog.2025.10.044_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","article-title":"Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention","volume":"146","author":"Dilley","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib29","doi-asserted-by":"crossref","first-page":"397.e391","DOI":"10.1016\/j.ajog.2021.03.032","article-title":"The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage","volume":"225","author":"Naumann","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib31","doi-asserted-by":"crossref","first-page":"399.e391","DOI":"10.1016\/j.ajog.2021.06.074","article-title":"Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States","volume":"225","author":"Mandelbaum","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1940-6207.CAPR-21-0121","article-title":"Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States","volume":"14","author":"Karia","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ajog.2025.10.044_bib33","doi-asserted-by":"crossref","first-page":"270.e271","DOI":"10.1016\/j.ajog.2016.10.035","article-title":"The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States","volume":"216","author":"Hanley","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2025.10.044_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.10.044_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2025.10.044_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.10.044_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2018.03.043","article-title":"Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise?","volume":"225","author":"Ntoumanoglou-Schuiki","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2025.10.044_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients' and professionals' perspectives","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2025.10.044_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ijgc-2023-004377","article-title":"TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol","volume":"33","author":"Steenbeek","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2025.10.044_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000005781","article-title":"Optimization of timing for risk-reducing salpingectomy and oophorectomy","volume":"145","author":"Pennington","year":"2025","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07357907.2016.1242597","article-title":"Physicians' perspectives and practice patterns toward opportunistic salpingectomy in High- and low-risk women","volume":"35","author":"Jones","year":"2017","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ajog.2025.10.044_bib45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s11912-024-01587-6","article-title":"Prevention of ovarian cancer: where are we now and where are we going?","volume":"26","author":"Rodriguez","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ajog.2025.10.044_bib46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2025.10.044_bib47","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib48","doi-asserted-by":"crossref","first-page":"425.e421","DOI":"10.1016\/j.ajog.2017.06.004","article-title":"Persistence of fimbrial tissue on the ovarian surface after salpingectomy","volume":"217","author":"Gan","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.10.044_bib49","series-title":"SGO clinical practice statement: salpingectomy for ovarian cancer prevention","year":"2013"},{"key":"10.1016\/j.ajog.2025.10.044_bib50","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ijgo.15884","article-title":"FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"167","author":"Mor-Hadar","year":"2024","journal-title":"Int J Gynaecol Obstet"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825008208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:38:31Z","timestamp":1787380711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825008208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0002937825008208"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.10.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}